Covered recipient · General Payments record
DONALD J CHADWICK
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology with Special Qualifications in Child Neurology
General Payments · PY2018–2024
$882.37
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $149.33 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $23.94 | 1 |
| JAZZ PHARMACEUTICALS INC. | $21.16 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.40 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $17.44 | 1 |
| Neurelis, Inc. | $15.49 | 1 |
| SK Life Science, Inc. | $14.96 | 1 |
| EISAI INC. | $14.14 | 1 |
| Mylan Specialty L.P. | $13.97 | 1 |
| Corium, Inc. | $9.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | $17.44 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144449246 | CMS |
| Corium, LLC | $9.83 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100123218 | CMS |
| Eisai Inc. | $14.14 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110742421 | CMS |
| JAZZ PHARMACEUTICALS INC. | $21.16 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150222542 | CMS |
| Mylan Specialty L.P. | $13.97 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147300561 | CMS |
| Neurelis, Inc. | $15.49 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145637067 | CMS |
| SK Life Science, Inc. | $14.96 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154148088 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.40 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137505868 | CMS |
| UCB, Inc. | $23.94 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143054539 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.